We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
Hot Features
Premium
RNS Number:7367Q
Celsis International PLC
05 February 2007
Celsis International plc
("the Company")
Holding in Company
5 February 2007: Celsis International plc announces that it received
notification on 5 February 2007 that, as at 1 February 2007, Barclays PLC had a
notifiable interest in 2,665,882 ordinary shares in the Company. The registered
holders of these ordinary shares are Barclays Global Investors Ltd, Barclays
Life Assurance Co Ltd, Barclays Stockbrokers Ltd and Gerrard Ltd.
The notifiable interest represents approximately 12.07 per cent. of the issued
share capital of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVOVRBSRURAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
